1. Home
  2. NNBR vs ENTX Comparison

NNBR vs ENTX Comparison

Compare NNBR & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NN Inc.

NNBR

NN Inc.

N/A

Current Price

$3.36

Market Cap

162.5M

Sector

Industrials

ML Signal

N/A

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$2.99

Market Cap

147.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NNBR
ENTX
Founded
1980
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.5M
147.4M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
NNBR
ENTX
Price
$3.36
$2.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$9.00
AVG Volume (30 Days)
2.8M
335.2K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
3.60
N/A
EPS
N/A
0.22
Revenue
$770,657,000.00
$42,000.00
Revenue This Year
$8.60
N/A
Revenue Next Year
$6.30
N/A
P/E Ratio
N/A
$13.27
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.91
52 Week High
$4.48
$4.20

Technical Indicators

Market Signals
Indicator
NNBR
ENTX
Relative Strength Index (RSI) 44.71 50.66
Support Level $2.99 $2.66
Resistance Level $4.39 $3.10
Average True Range (ATR) 0.20 0.23
MACD -0.06 -0.07
Stochastic Oscillator 11.47 13.17

Price Performance

Historical Comparison
NNBR
ENTX

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: